Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-18
2008-03-18
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S273700
Reexamination Certificate
active
07345061
ABSTRACT:
The present invention relates to new salts of omeprazole and esomeprazole respectively, i.e. salts of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzirnidazole and the (S)-enantiomer thereof. More specifically, the present invention relates to alkylammonium salts of the compounds, formed by a reaction of omeprazole and esomeprazole respectively and an alkylamine with formula NR1R2R3, wherein R1is a linear, branched, or cyclic C1-C12-alkyl group, and R2and R3are hydrogen. The present invention also relates to a process for preparing crystalline salts, a pharmaceutical preparation, and a method for treatment of gastric related disorders by administering the compound of the invention.
REFERENCES:
patent: 0005129 (1979-10-01), None
patent: 0124495 (1984-11-01), None
patent: 0247983 (1987-02-01), None
patent: WO-94/27988 (1994-12-01), None
patent: WO-96/01623 (1996-01-01), None
patent: WO-96/02535 (1996-02-01), None
patent: WO-97/41114 (1997-11-01), None
patent: WO-98/54171 (1998-12-01), None
Astrazeneca AB
Morris Patricia L.
White & Case LLP
LandOfFree
Alkylammonium salts of omeprazole and esomeprazole does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkylammonium salts of omeprazole and esomeprazole, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkylammonium salts of omeprazole and esomeprazole will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2813137